Organogenesis Holdings (ORGO) Share-based Compensation Growth (1y) (2019 - 2026)
Organogenesis Holdings (ORGO) Share-based Compensation Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 239.33 Mn | 192.49 Mn | 20.08 Mn | 823.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 823.92% |
| Mar 31, 2026 | 102.45% |
| Dec 31, 2025 | -280.11% |
| Sep 30, 2025 | 13.02% |
| Jun 30, 2025 | 427.38% |
| Mar 31, 2025 | 156.21% |
| Dec 31, 2024 | 438.44% |
| Sep 30, 2024 | 12.21% |
| Jun 30, 2024 | 11.70% |
| Mar 31, 2024 | -63.38% |
| Dec 31, 2023 | 4.13% |
| Sep 30, 2023 | 42.01% |
| Jun 30, 2023 | 35.87% |
| Mar 31, 2023 | 1,019.30% |
| Dec 31, 2022 | -96.97% |
| Sep 30, 2022 | 63.50% |
| Jun 30, 2022 | 62.38% |
| Mar 31, 2022 | -75.50% |
| Dec 31, 2021 | 466.07% |
| Sep 30, 2021 | -85.76% |